Andere Sprachen Sanofi India Limited

Aktien

946019

INE058A01010

SANOFI

Markt geschlossen - Bombay S.E. Andere Börsenplätze 12:00:50 03.05.2024			% 5 Tage	% 1. Jan.
8’617 ^INR	-0.72%		+5.82%	+6.81%

15.04.	Sanofi India Limited gibt die Ernennung von Flovie Martins zur Leiterin der Unternehmenskommunikation und der sozialen Verantwortung des Unternehmens bekannt	CI
28.03.	Sanofi India Limited gibt den Rücktritt von Marc-Antoine Lucchini als Non-Executive Director und Mitglied des Nominierungs- und Vergütungsausschusses bekannt	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Sanofi India Limited Announces Appointment of Flovie Martins as Head of Corporate Communications and Corporate Social Responsibility	15.04.
Sanofi India Limited Announces Resignation of Marc-Antoine Lucchini as Non-Executive Director from the Board of Directors, Member of the Nomination and Remuneration Committee	28.03.
Cipla to Distribute Sanofi's CNS Product Line in India	27.03.
Sanofi India Limited, Sanofi Healthcare India Private Limited and Cipla Limited Announce an Exclusive Partnership	26.03.
Sanofi India Limited and Emcure Pharmaceuticals Announces Exclusive Distribution Partnership to Broad Broadline Reach of Sanofi's Cardiovascular Brands	13.03.
Sanofi India Limited Recommends Final Dividend for the Financial Year Ended 31St December 2023, Payable on or After 24 May 2024	23.02.
Sanofi India Limited Declares Interim Dividend for the Financial Year Ended 31St December, 2023, Payable on or After 20 March, 2024	23.02.
Sanofi India Limited Reports Earnings Results for the Full Year Ended December 31, 2023	23.02.
Sanofi India Limited Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	23.02.
Sanofi India Limited Appoints Radhika Shah as Head of Legal, Effective 15 January 2024	10.01.
Sanofi India appoints Himanshu Bakshi as General Manager for its Consumer Healthcare business	20.12.
Sanofi Sees Improvement in Trial Results of Cancer Drug Sarclisa	11.12.
Trending : Merck's Multiple Sclerosis Drug Misses Expectations in Late-Stage Trials	06.12.
Sanofi India's CFO Steps Down	09.11.
Sanofi India Limited Announces the Resignation of Vaibhav Karandikar as Whole-Time Director	08.11.
Sanofi India Limited Announces the Resignation of Vaibhav Karandikar as Chief Financial Officer, effective November 30, 2023	08.11.
Sanofi India Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	08.11.
Sanofi India Limited Appoints Surabhi Kaul as India People Director and Will Be Part of the Senior Management Personnel	17.10.23
Sanofi India Limited Announces Executive Changes	26.09.23
Sanofi India Limited Announces Resignation of Vinita Korti Patil as Senior Legal Director - South Asia, Effective 7 December 2023	14.09.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Sanofi India Limited

Aktien

946019

INE058A01010

SANOFI

Andere Sprachen

Filter